CML patients in blast crisis present with higher expression of MDR1 compared to CML patients in the chronic phase, and MDR1 upregulation has been associated with decreased sensitivity to chemotherapy in advanced-phase disease [147,150]. This evidence concerns the gene ABCB1 and chronic myelogenous leukemia, BCR-ABL1 positive.